Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention

PURPOSE OF REVIEW: Recent breakthroughs in HIV-prevention science led us to evaluate the current state of combination HIV prevention for injection drug users (IDUs). We review the recent literature focusing on possible reasons why coverage of prevention interventions for HIV, hepatitis C virus (HCV)...

Full description

Saved in:
Bibliographic Details
Main Authors: Strathdee S., Shoptaw S., Dyer T., Quan V., Aramrattana A.
Format: Journal
Published: 2017
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84862565059&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/42815
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-42815
record_format dspace
spelling th-cmuir.6653943832-428152017-09-28T06:40:03Z Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention Strathdee S. Shoptaw S. Dyer T. Quan V. Aramrattana A. PURPOSE OF REVIEW: Recent breakthroughs in HIV-prevention science led us to evaluate the current state of combination HIV prevention for injection drug users (IDUs). We review the recent literature focusing on possible reasons why coverage of prevention interventions for HIV, hepatitis C virus (HCV) and tuberculosis among IDUs remains dismal. We make recommendations for future HIV research and policy. RECENT FINDINGS: IDUs disproportionately under-utilize voluntary HIV counseling and testing (VCT), primary care and antiretroviral therapy (ART), especially in countries that have the largest burden of HIV among IDUs. IDUs present later in the course of HIV infection and experience greater morbidity and mortality. Why are IDUs under-represented in HIV-prevention research, access to treatment for both HIV and addiction, and access to HIV combination prevention? Possible explanations include addictophobia, apathy, and inattention, which we describe in the context of recent literature and events. SUMMARY: This commentary discusses the current state of HIV-prevention interventions for IDUs including VCT, needle and syringe program (NSP), opioid substitution therapy (OST), ART and pre-exposure chemoprophylaxis (PrEP), and discusses ways to work towards true combination HIV prevention for IDU populations. Communities need to overcome tacit assumptions that IDUs can navigate through systems that are maintained as separate silos, and begin to take a rights-based approach to HIV prevention to ensure that IDUs have equitable access to life-saving prevention and treatments. Copyright © Lippincott Williams & Wilkins. 2017-09-28T06:40:03Z 2017-09-28T06:40:03Z 2012-07-01 Journal 1746630X 2-s2.0-84862565059 10.1097/COH.0b013e32835369ad https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84862565059&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42815
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
description PURPOSE OF REVIEW: Recent breakthroughs in HIV-prevention science led us to evaluate the current state of combination HIV prevention for injection drug users (IDUs). We review the recent literature focusing on possible reasons why coverage of prevention interventions for HIV, hepatitis C virus (HCV) and tuberculosis among IDUs remains dismal. We make recommendations for future HIV research and policy. RECENT FINDINGS: IDUs disproportionately under-utilize voluntary HIV counseling and testing (VCT), primary care and antiretroviral therapy (ART), especially in countries that have the largest burden of HIV among IDUs. IDUs present later in the course of HIV infection and experience greater morbidity and mortality. Why are IDUs under-represented in HIV-prevention research, access to treatment for both HIV and addiction, and access to HIV combination prevention? Possible explanations include addictophobia, apathy, and inattention, which we describe in the context of recent literature and events. SUMMARY: This commentary discusses the current state of HIV-prevention interventions for IDUs including VCT, needle and syringe program (NSP), opioid substitution therapy (OST), ART and pre-exposure chemoprophylaxis (PrEP), and discusses ways to work towards true combination HIV prevention for IDU populations. Communities need to overcome tacit assumptions that IDUs can navigate through systems that are maintained as separate silos, and begin to take a rights-based approach to HIV prevention to ensure that IDUs have equitable access to life-saving prevention and treatments. Copyright © Lippincott Williams & Wilkins.
format Journal
author Strathdee S.
Shoptaw S.
Dyer T.
Quan V.
Aramrattana A.
spellingShingle Strathdee S.
Shoptaw S.
Dyer T.
Quan V.
Aramrattana A.
Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention
author_facet Strathdee S.
Shoptaw S.
Dyer T.
Quan V.
Aramrattana A.
author_sort Strathdee S.
title Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention
title_short Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention
title_full Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention
title_fullStr Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention
title_full_unstemmed Towards combination HIV prevention for injection drug users: Addressing addictophobia, apathy and inattention
title_sort towards combination hiv prevention for injection drug users: addressing addictophobia, apathy and inattention
publishDate 2017
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84862565059&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/42815
_version_ 1681422261046738944